New ADHD Medication Is On Track For NDA Filing Within A Year - Hear From This Biotech's CEO - Cingulate ( NASDAQ:CING )

2 weeks ago

Dr. Ann Childress and Shane Schaffer, Chairman & CEO of Cingulate CING, were recently guests on Benzinga's All Access. Cingulate is a biotechnology company developing drugs for a range of underserved conditions. The company has developed a proprietary technology called Precision Timed Release™ ( ...

Ticker	Sentiment	Impact
CING	Somewhat Bearish	79 %